Ascensia Diabetes Care Belgium
0636.787.578 · rovalta.com · 27/09/2026
ACTIVE
Ascensia Diabetes Care Belgium
Financial year 2025 · Closed on 31/03/2025
Net result212,8 k €+5,6 %over 1 year
Gross margin1,4 M €-15,3 %over 1 year
Equity1,4 M €+18,4 %over 1 year
Workforce8,0 ETP-3,6 %over 1 year
Overview
Identity
Source · BCE/KBOAscensia Diabetes Care Belgium is a Public limited company incorporated in 2015. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 8,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0636.787.578
- Incorporation
- 04/09/2015
- Legal form
- Public limited company
- Registered office
- De Kleetlaan 5BC
1831 Machelen (Brab.) · FlandreSee on map - Contributed capital
- 931 906,00 €
- Latest accounts
- 31/03/2025
- Average workforce
- 8,0 ETP
Activities (NACE)
Joint committees (1)
- 207
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 9 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,4 M € | -15.3% | 1,6 M € | +5.1% | 1,6 M € | -21.8% | 2 M € | – | |
| EBITDA | 311,7 k € | +0.2% | 311 k € | +45.7% | 213,4 k € | -26.0% | 288,4 k € | -32.7% | 428,3 k € |
| Operating result | 310,1 k € | +0.2% | 309,3 k € | +95.5% | 158,2 k € | -26.5% | 215,3 k € | +5.0% | 205,2 k € |
| Net result | 212,8 k € | +5.6% | 201,6 k € | +125% | 89,7 k € | -33.4% | 134,7 k € | +4.8% | 128,5 k € |
| Balance sheet | |||||||||
| Equity | 1,4 M € | +18.4% | 1,2 M € | +21.1% | 957,2 k € | -29.0% | 1,3 M € | +11.1% | 1,2 M € |
| Total assets | 2,3 M € | +12.8% | 2 M € | -23.8% | 2,7 M € | +9.1% | 2,4 M € | +11.1% | 2,2 M € |
| Cash | 1,3 M € | +56.3% | 856,3 k € | -38.2% | 1,4 M € | +30.4% | 1,1 M € | +148% | 428,1 k € |
| Debts | 919,4 k € | +5.4% | 872,5 k € | -48.9% | 1,7 M € | +55.8% | 1,1 M € | +14.8% | 955 k € |
| Other | |||||||||
| Workforce | 8,0 ETP | -3.6% | 8,3 ETP | -19.4% | 10,3 ETP | +10.8% | 9,3 ETP | -11.4% | 10,5 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/03/20251 active · 3 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Christophe De Rudder | Director | since 21/06/2016 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Christophe De Rubber | Director | since 21/06/2016 |
Torstein Myhre | Director | 21/06/2016 → 12/02/2021 |
Torstein Myhre | Director | since 21/06/2016 |
Other companies at this address
De Kleetlaan 5BC 1831 Machelen (Brab.)| Company | CBE no. |
|---|---|
AAMAL EUROPE INVESTMENT● Active | 0793.992.906 |
ABND Drinks Company Belux● Active | 1041.703.685 |
Access Advisors● Active | 0745.619.994 |
Accuray Belgium● Active | 0893.897.659 |
Aidian Belgium● Active | 0780.755.473 |
ALH Cie● Active | 1025.449.554 |
ARL GROUP● Active | 1034.195.489 |
ATIS● Active | 0898.887.122 |
Autodoc Belgium● Active | 1015.401.839 |
BIOCON BIOLOGICS BELGIUM● Active | 0801.406.278 |
Corza Medical● Active | 0759.493.073 |
Cyclomedia Belgium● Active | 1011.495.313 |
D.O.S.● Active | 0648.910.796 |
DRAAK BOKEN● Active | 1010.997.049 |
EM&S CONSTRUCT● Active | 0781.966.290 |
Epredia Belgium● Active | 0725.526.346 |
EUZCN● Active | 0668.536.074 |
Fortinet Belgium BV● Active | 0736.509.320 |
GG One● Active | 1027.105.878 |
GLOBIS Europe● Active | 0788.604.357 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Full model | Full model |
| Start of the financial year | 01/04/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 09/10/2025 | 23/10/2024 | 31/10/2023 | 13/04/2023 | 03/12/2021 | 23/02/2021 |
| General meeting | 25/09/2025 | 26/09/2024 | 19/10/2023 | 12/12/2022 | 29/10/2021 | 22/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/03/2025 | 25/09/2025 | 09/10/2025 | Dutch | |
| Abridged model | 31/03/2024 | 26/09/2024 | 23/10/2024 | Dutch | |
| Abridged model | 31/03/2023 | 19/10/2023 | 31/10/2023 | Dutch | |
| Abridged model | 31/03/2022 | 12/12/2022 | 13/04/2023 | Dutch | |
| Full model | 31/03/2021 | 29/10/2021 | 03/12/2021 | Dutch | |
| Full model | 31/03/2020 | 22/12/2020 | 23/02/2021 | Dutch | |
| Full model | 31/03/2019 | 16/11/2019 | 09/12/2019 | Dutch | |
| Full model | 31/03/2018 | 22/10/2018 | 09/11/2018 | Dutch | |
| Full model | 31/03/2017 | 20/11/2017 | 29/11/2017 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20251 active · 3 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Christophe De Rudder | Director | since 21/06/2016 |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Christophe De Rubber | Director | since 21/06/2016 |
Torstein Myhre | Director | 21/06/2016 → 12/02/2021 |
Torstein Myhre | Director | since 21/06/2016 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other17/07/2026Hernieuwing mandaat commissaris - Volmacht
- Registered office30/12/2025MAATSCHAPPELIJKE ZETEL
- Mandates02/12/2025ONTSLAGEN - BENOEMINGEN
- Mandates20/08/2024ONTSLAGEN - BENOEMINGEN
- Mandates21/11/2023ONTSLAGEN - BENOEMINGEN
- Mandates04/11/2021ONTSLAGEN - BENOEMINGEN
- Mandates18/02/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
- Other03/09/2019STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025212,8 k €↑
- 2024Annual accounts 2024201,6 k €↑
- 2023Annual accounts 202389,7 k €↓
- 2022Annual accounts 2022134,7 k €↑
- 2021Annual accounts 2021128,5 k €↓
- 2020Annual accounts 2020136,4 k €↑
- 2019Annual accounts 2019125,3 k €↓
- 2018Annual accounts 2018519,9 k €
- 04/09/2015IncorporationPublic limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| De Kleetlaan 5BC, 1831 DiegemCurrent | CBE, tracked since 27/09/2026 | CBE |
| Pegasuslaan 5, 1831 Diegem | accounts 2022 → 2025 | Accounts 2025 · 2025-00538565 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.